Nevro LLC Stock

Nevro LLC FCF Conversion

Delisted·Apr 2, 2025

The FCF Conversion Rate (FCF/EBITDA) of Nevro LLC (NVRO) as of Aug 15, 2026 is 25.76 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 73.12 % — a change of -64.76% (lower).

FCF Conversion

25.76 %

YoY

-64.76%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Nevro LLC is 2026 25.76 % . FCF Conversion Rate (FCF/EBITDA) of Nevro LLC was 2025 73.12 % . It decreases by -64.76% lower compared to the previous year.
Access this data via the Eulerpool API

Nevro LLC Stock analysis

What does Nevro LLC do? Nevro Corp is a global leader in innovative medical products and therapy systems. The company was founded in 2006 and is headquartered in Redwood City, California. Nevro Corp is a pioneer in the development of novel implantable medical technologies and has brought a variety of products to the market since its founding, enabling revolutionary advances in pain therapy. Nevro Corp's business model is based on the production, marketing, and sale of implantable neuromodulation devices that can reduce or even eliminate chronic pain in patients. These devices are able to send electrical signals to individual nerve fibers to target and treat pain in specific areas of the body. With this innovative technology, Nevro Corp has revolutionized the pain therapy market and filled a niche that conventional treatment methods could not address. Nevro Corp has various divisions and branches worldwide. An important area of the company is research and development, where new and innovative pain therapy technologies are constantly being developed. Another division is marketing, where the company's products are sold to medical specialists, hospitals, and clinics worldwide. In addition, Nevro Corp also offers training and education to inform medical professionals about the company and its products. The products offered by Nevro Corp include implantable neuromodulation systems such as the Senza system and the HF10 system. The Senza system is a spinal cord stimulator that is controlled via a remote and sends electrical impulses to the spinal cord to relieve pain in the arms, legs, and back. The HF10 system works with high-frequency technology and was developed to treat chronic pain in the lower back. In addition to these products, Nevro Corp has also introduced a range of accessories and enhancements to facilitate the operation and maintenance of the implantable devices. These include, for example, wireless chargers or a special remote control that allows patients to individually adjust their therapy. In summary, Nevro Corp is an innovative and successful provider of medical products and therapy systems specializing in pain therapy. With sophisticated technology, state-of-the-art research and development, and a dedicated workforce, the company has made a significant contribution to improving the quality of life for millions of patients worldwide and will continue to develop innovative and effective therapies in the future. Nevro LLC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nevro LLC stock

FCF Conversion Rate (FCF/EBITDA) of Nevro LLC is 25.76 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Nevro LLC changed from 73.12 % to 25.76 %, representing a -64.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Nevro LLC since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Nevro LLC with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Nevro LLC

All Key Metrics — Nevro LLC